Here is yet another day when an ARK Invest exchange-traded fund run by ETF star Cathie Wood parted with even more Pfizer Inc. (NYSE: PFE) shares. Specifically, the fund sold over 400,000 more shares, as the price of this ETF was flat in the day’s session. However, it is up in the past year.
It was ARK Genomic Revolution ETF (NYSEARCA: ARKG) that shed 407,075 shares of Pfizer. At Thursday’s closing price, this would have valued this sale at roughly $20.4 million. This is only a small fraction of the total holdings. The fund is up about 1.5% over the past 52 weeks.
Check out all the ARK Invest sales for Thursday:
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St., owner of 247wallst.com.
Sponsored: Tips for Investing
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.